Related Experiment Video
Updated: Mar 1, 2026

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
Published on: January 19, 2024
Erythrasma: A report of nine men successfully managed with mupirocin 2% ointment monotherapy
Tanya Greywal1, Philip R Cohen
1Department of Dermatology, University of California San Diego, San Diego, California. tgreywal@gmail.com.
Background:
Erythrasma is a benign dermatosis that typically occurs on intertriginous skin.
Purpose:
We describe a series of nine men with erythrasma that were successfully treated with mupirocin 2% ointment monotherapy.
Methods And Materials:
We reviewed PubMed for the following terms: erythrasma, mupirocin, ointment, treatment. We also reviewed papers containing these terms and their references.
Results:
Complete resolution of erythrasma occurred following monotherapy with twice daily application of mupirocin 2% ointment.
Conclusions:
Several topical and oral treatments are available to successfully manage erythrasma. Our series of patients with erythrasma experienced resolution with mupirocin 2% ointment treatment within 2 to 4 weeks of therapy. Monotherapy with mupirocin 2% ointment should be considered as a primary treatment alternative for erythrasma.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Hand hygiene
Hand washing...
Myocarditis III: Medical Management
Endocarditis III: Medical Management
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Acute Pyelonephritis II: Diagnostic Studies and Management

